[Chemonucleolysis in the treatment of sciatica caused by herniated disk]

Area of Science:

• Neurosurgery
• Minimally Invasive Procedures
• Pain Management

Background:

• Sciatica resulting from herniated lumbar discs often requires intervention after conservative treatments prove ineffective.
• Surgical options for herniated discs carry risks and may not always be the optimal first-choice treatment.
• Chemonucleolysis offers a less invasive alternative for specific patient profiles.

Purpose of the Study:

• To evaluate the efficacy of chemonucleolysis as a treatment for sciatica caused by herniated lumbar discs.
• To determine if chemonucleolysis complicates subsequent surgical interventions.
• To position chemonucleolysis within the spectrum of conservative management for lumbar disc herniation.

Main Methods:

• Chemonucleolysis involves the injection of chymopapain to dissolve disc nucleus material.
• Patient selection criteria are crucial, excluding cases of complete herniation or narrow spinal canals.
• Data on treatment outcomes and subsequent surgical necessity were analyzed.

Main Results:

• Chemonucleolysis is effective in treating sciatica when conservative treatments have failed.
• The majority of patients can avoid surgery through chemonucleolysis with proper technique and patient selection.
• Subsequent surgery after chemonucleolysis yields results comparable to primary surgical intervention.

Conclusions:

• Chemonucleolysis should be considered the final conservative treatment step before surgery for herniated lumbar discs.
• The procedure does not negatively impact outcomes of necessary future surgeries.
• Careful patient selection and technique are paramount to minimize risks, primarily allergic reactions.